Platelet BioGenesis

Platelet BioGenesis

Signal active

Organization

Contact Information

Overview

Platelet BioGenesis specializes in the fields of biotechnology, platelets, and drug discovery. They discover a new category in therapeutics. The company is developing technology to produce donor-independent human platelets from human induced pluripotent stem cells.

About

Industries

Biotechnology, Life Science, Ediscovery, Product Research

Founded

2014

Employees

11-50

Headquarters locations

United States, North America

Social

N/A

Profile Resume

Platelet BioGenesis headquartered in United States, North America, operates in the Biotechnology, Life Science, Ediscovery, Product Research sector. The company focuses on Biotechnology and has secured $29.6B in funding across 224 round(s). With a team of 11-50 employees, Platelet BioGenesis is actively contributing to advancements in Biotechnology. Their latest funding round, Debt Financing - Platelet BioGenesis, raised $1.1M. Discover more about their projects, partnerships, and impact on our platform.

Employees

imagePlace Jonathan Thon

Jonathan Thon

Founder

imagePlace Joseph Italiano

Joseph Italiano

Co-Founder

imagePlace Sven Karlsson

Sven Karlsson

Co-Founder and Chief Operating Officer

Funding Rounds

Funding rounds

14

Investors

0

Lead Investors

0

Total Funding Amount

$132.1M

Details

7

Platelet BioGenesis has raised a total of $132.1M in funding over 7 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor
2019Early Stage Venture
2015Seed
2021Early Stage Venture75.5M
2017Early Stage Venture10.0M

Investors

Platelet BioGenesis is funded by 33 investors.

Investor NameLead InvestorFunding RoundPartners
Vivo Capital-FUNDING ROUND - Vivo Capital10.0M
Ecoast Angel Network-FUNDING ROUND - Ecoast Angel Network10.0M
Viventures-FUNDING ROUND - Viventures10.0M
Platelet BioGenesis-FUNDING ROUND - Platelet BioGenesis10.0M

Recent Activity

There is no recent news or activity for this profile.